 David Allen
Concepts (455)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myostatin | 9 | 2011 | 26 | 2.470 |
Why?
| | Muscle, Skeletal | 34 | 2015 | 1515 | 2.300 |
Why?
| | Muscle Fibers, Skeletal | 16 | 2011 | 192 | 2.100 |
Why?
| | Myosin Heavy Chains | 18 | 2011 | 192 | 1.900 |
Why?
| | Antigens, Human Platelet | 7 | 2013 | 8 | 1.550 |
Why?
| | Isoantibodies | 6 | 2013 | 63 | 1.260 |
Why?
| | Food Deprivation | 4 | 2010 | 24 | 1.230 |
Why?
| | Gene Expression Regulation | 11 | 2010 | 2445 | 1.090 |
Why?
| | Muscular Atrophy | 4 | 2010 | 80 | 1.080 |
Why?
| | Physical Conditioning, Animal | 7 | 2020 | 204 | 1.020 |
Why?
| | Muscle Fibers, Fast-Twitch | 7 | 2010 | 15 | 1.010 |
Why?
| | Promoter Regions, Genetic | 12 | 2010 | 1158 | 0.990 |
Why?
| | Adaptation, Physiological | 9 | 2011 | 502 | 0.970 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2013 | 127 | 0.920 |
Why?
| | Hindlimb | 6 | 2011 | 137 | 0.760 |
Why?
| | Calcineurin | 5 | 2010 | 95 | 0.720 |
Why?
| | Integrin beta3 | 4 | 2013 | 9 | 0.650 |
Why?
| | Blood Platelets | 3 | 2011 | 369 | 0.630 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1323 | 0.630 |
Why?
| | Exercise | 4 | 2015 | 1657 | 0.590 |
Why?
| | Edetic Acid | 3 | 2013 | 47 | 0.580 |
Why?
| | Thrombocytopenia, Neonatal Alloimmune | 2 | 2013 | 2 | 0.570 |
Why?
| | Myoblasts | 3 | 2008 | 75 | 0.560 |
Why?
| | Hindlimb Suspension | 4 | 2010 | 24 | 0.550 |
Why?
| | Mice | 35 | 2011 | 15520 | 0.550 |
Why?
| | RNA, Messenger | 14 | 2010 | 2657 | 0.520 |
Why?
| | Elbow Joint | 2 | 2015 | 63 | 0.500 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 462 | 0.500 |
Why?
| | Animals | 54 | 2020 | 33381 | 0.490 |
Why?
| | Space Flight | 4 | 2008 | 129 | 0.480 |
Why?
| | Muscle Development | 5 | 2010 | 102 | 0.480 |
Why?
| | Integrin alpha2 | 1 | 2013 | 3 | 0.470 |
Why?
| | Chelating Agents | 1 | 2013 | 74 | 0.450 |
Why?
| | Weightlessness | 4 | 2008 | 80 | 0.440 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2011 | 22 | 0.430 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 17 | 0.420 |
Why?
| | Dexamethasone | 2 | 2010 | 320 | 0.410 |
Why?
| | Organ Size | 12 | 2010 | 460 | 0.400 |
Why?
| | CCAAT-Enhancer-Binding Protein-delta | 1 | 2010 | 4 | 0.390 |
Why?
| | Transcription Factors | 6 | 2020 | 1570 | 0.390 |
Why?
| | Tolloid-Like Metalloproteinases | 1 | 2010 | 1 | 0.380 |
Why?
| | Bone Morphogenetic Protein 1 | 1 | 2010 | 1 | 0.380 |
Why?
| | Smad Proteins | 2 | 2010 | 39 | 0.380 |
Why?
| | Elbow | 1 | 2011 | 54 | 0.380 |
Why?
| | Mice, Inbred C57BL | 12 | 2011 | 4908 | 0.380 |
Why?
| | Molecular Sequence Data | 10 | 2010 | 2871 | 0.380 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2010 | 84 | 0.360 |
Why?
| | Epitopes | 2 | 2011 | 443 | 0.360 |
Why?
| | Physical Exertion | 5 | 2015 | 222 | 0.330 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2008 | 80 | 0.330 |
Why?
| | Protein Isoforms | 7 | 2008 | 345 | 0.320 |
Why?
| | DNA, Intergenic | 1 | 2008 | 25 | 0.320 |
Why?
| | Activin Receptors, Type II | 1 | 2008 | 9 | 0.320 |
Why?
| | CLOCK Proteins | 2 | 2020 | 10 | 0.320 |
Why?
| | Genes, MHC Class II | 1 | 2008 | 72 | 0.320 |
Why?
| | Adipose Tissue | 3 | 2011 | 606 | 0.320 |
Why?
| | Motor Activity | 7 | 2005 | 660 | 0.320 |
Why?
| | Base Sequence | 7 | 2010 | 2159 | 0.310 |
Why?
| | Antibodies, Monoclonal | 4 | 2011 | 1284 | 0.300 |
Why?
| | Muscle Fibers, Slow-Twitch | 5 | 2010 | 13 | 0.300 |
Why?
| | MicroRNAs | 2 | 2010 | 637 | 0.290 |
Why?
| | Genotype | 4 | 2011 | 1882 | 0.290 |
Why?
| | Obesity | 2 | 2011 | 2746 | 0.290 |
Why?
| | Drosophila Proteins | 3 | 2020 | 171 | 0.290 |
Why?
| | Transfection | 7 | 2008 | 888 | 0.280 |
Why?
| | Cell Nucleus | 7 | 2001 | 580 | 0.280 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2007 | 117 | 0.280 |
Why?
| | Circadian Rhythm | 3 | 2020 | 401 | 0.270 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 827 | 0.270 |
Why?
| | Interleukin-6 | 1 | 2009 | 688 | 0.270 |
Why?
| | Calcium Signaling | 2 | 2009 | 219 | 0.270 |
Why?
| | Forkhead Transcription Factors | 1 | 2006 | 182 | 0.260 |
Why?
| | Muscular Diseases | 2 | 2011 | 107 | 0.260 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2004 | 5 | 0.260 |
Why?
| | Serum Response Factor | 1 | 2005 | 31 | 0.260 |
Why?
| | Platelet Transfusion | 2 | 2004 | 68 | 0.260 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2003 | 287 | 0.250 |
Why?
| | DNA-Binding Proteins | 4 | 2009 | 1346 | 0.250 |
Why?
| | Growth Hormone | 4 | 1998 | 108 | 0.250 |
Why?
| | Physical Endurance | 2 | 2002 | 231 | 0.240 |
Why?
| | Cells, Cultured | 8 | 2010 | 4077 | 0.230 |
Why?
| | Cell Differentiation | 3 | 2010 | 1753 | 0.230 |
Why?
| | Infant, Newborn, Diseases | 1 | 2004 | 106 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2011 | 2062 | 0.220 |
Why?
| | Growth Substances | 1 | 2002 | 136 | 0.220 |
Why?
| | Male | 26 | 2022 | 57801 | 0.210 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 982 | 0.210 |
Why?
| | Stress, Psychological | 1 | 2010 | 972 | 0.210 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 175 | 0.210 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 90 | 0.210 |
Why?
| | Proteins | 1 | 2008 | 938 | 0.210 |
Why?
| | Rats | 12 | 2011 | 5392 | 0.200 |
Why?
| | Nuclear Proteins | 3 | 2006 | 597 | 0.200 |
Why?
| | Cell Line | 5 | 2010 | 2707 | 0.190 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2006 | 814 | 0.190 |
Why?
| | Mice, Transgenic | 5 | 2011 | 2025 | 0.190 |
Why?
| | Proteomics | 3 | 2020 | 876 | 0.180 |
Why?
| | Circadian Clocks | 1 | 2020 | 48 | 0.180 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 53 | 0.180 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2020 | 40 | 0.180 |
Why?
| | Heart | 4 | 2005 | 631 | 0.180 |
Why?
| | Bariatric Surgery | 1 | 2022 | 166 | 0.180 |
Why?
| | Acclimatization | 1 | 2001 | 135 | 0.180 |
Why?
| | Drosophila | 1 | 2020 | 140 | 0.170 |
Why?
| | Binding Sites | 5 | 2007 | 1224 | 0.170 |
Why?
| | Corticosterone | 2 | 2010 | 253 | 0.170 |
Why?
| | Mutation | 4 | 2011 | 3457 | 0.170 |
Why?
| | Fibronectins | 4 | 2002 | 114 | 0.170 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2009 | 332 | 0.160 |
Why?
| | Weight-Bearing | 3 | 2001 | 172 | 0.160 |
Why?
| | Muscle Proteins | 2 | 2010 | 219 | 0.160 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2174 | 0.160 |
Why?
| | Thrombocytopenia | 3 | 2004 | 185 | 0.150 |
Why?
| | Protein Binding | 3 | 2020 | 1975 | 0.140 |
Why?
| | Luciferases | 2 | 2008 | 143 | 0.140 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 394 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2010 | 2680 | 0.140 |
Why?
| | Calcium | 1 | 2002 | 1169 | 0.140 |
Why?
| | NFATC Transcription Factors | 2 | 2009 | 82 | 0.140 |
Why?
| | Glucocorticoids | 2 | 2010 | 545 | 0.140 |
Why?
| | Female | 22 | 2022 | 61565 | 0.140 |
Why?
| | Humans | 32 | 2022 | 118974 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 410 | 0.140 |
Why?
| | Microscopy, Confocal | 6 | 2001 | 314 | 0.130 |
Why?
| | Body Weight | 6 | 2003 | 934 | 0.130 |
Why?
| | Hypertrophy | 3 | 2001 | 121 | 0.130 |
Why?
| | Genetic Variation | 4 | 2007 | 926 | 0.120 |
Why?
| | Signal Transduction | 5 | 2009 | 4709 | 0.120 |
Why?
| | Bacterial Proteins | 2 | 2011 | 759 | 0.120 |
Why?
| | Immunoassay | 1 | 1994 | 101 | 0.120 |
Why?
| | Infant, Newborn | 5 | 2013 | 5255 | 0.120 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 25 | 0.120 |
Why?
| | Isometric Contraction | 2 | 2015 | 155 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 363 | 0.120 |
Why?
| | Aging | 2 | 2001 | 1670 | 0.120 |
Why?
| | Species Specificity | 2 | 2020 | 565 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 2071 | 0.110 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 24 | 0.110 |
Why?
| | Range of Motion, Articular | 2 | 2015 | 369 | 0.110 |
Why?
| | Education | 1 | 2013 | 105 | 0.110 |
Why?
| | Vancomycin Resistance | 2 | 2011 | 15 | 0.110 |
Why?
| | Weight Loss | 2 | 2022 | 655 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1440 | 0.110 |
Why?
| | Blotting, Western | 3 | 2010 | 1194 | 0.100 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1795 | 0.100 |
Why?
| | Gluconeogenesis | 2 | 2010 | 66 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2366 | 0.100 |
Why?
| | Antigen-Antibody Complex | 1 | 2011 | 90 | 0.100 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 63 | 0.100 |
Why?
| | Time Factors | 3 | 2010 | 6412 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2008 | 155 | 0.100 |
Why?
| | Apoptosis | 2 | 1999 | 2484 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 6 | 2003 | 2478 | 0.100 |
Why?
| | Muscle Fatigue | 2 | 2011 | 91 | 0.100 |
Why?
| | Genes, Bacterial | 2 | 2008 | 162 | 0.100 |
Why?
| | Proteome | 2 | 2007 | 353 | 0.100 |
Why?
| | Running | 1 | 2013 | 227 | 0.100 |
Why?
| | Torque | 1 | 2011 | 67 | 0.100 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2010 | 10 | 0.100 |
Why?
| | Glucokinase | 1 | 2010 | 13 | 0.090 |
Why?
| | Protein Kinase C | 2 | 2002 | 297 | 0.090 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 32 | 0.090 |
Why?
| | Tripartite Motif Proteins | 1 | 2010 | 31 | 0.090 |
Why?
| | 3T3 Cells | 3 | 2008 | 141 | 0.090 |
Why?
| | Mice, Obese | 2 | 2008 | 58 | 0.090 |
Why?
| | Phosphatidylethanolamine Binding Protein | 1 | 2009 | 1 | 0.090 |
Why?
| | DNA | 4 | 2008 | 1388 | 0.090 |
Why?
| | Oxazolidinones | 1 | 2009 | 14 | 0.090 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1691 | 0.090 |
Why?
| | Thymus Gland | 1 | 2010 | 300 | 0.090 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 148 | 0.090 |
Why?
| | Body Temperature Regulation | 2 | 2007 | 73 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2008 | 420 | 0.080 |
Why?
| | Adult | 8 | 2022 | 31512 | 0.080 |
Why?
| | Skeletal Muscle Myosins | 1 | 2008 | 2 | 0.080 |
Why?
| | RNA, Antisense | 1 | 2008 | 19 | 0.080 |
Why?
| | Follistatin-Related Proteins | 1 | 2008 | 1 | 0.080 |
Why?
| | Myogenic Regulatory Factors | 2 | 2005 | 51 | 0.080 |
Why?
| | MEF2 Transcription Factors | 2 | 2005 | 57 | 0.080 |
Why?
| | Spleen | 1 | 2010 | 510 | 0.080 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 217 | 0.080 |
Why?
| | ADP Ribose Transferases | 1 | 2007 | 10 | 0.080 |
Why?
| | Muscle Contraction | 1 | 2011 | 413 | 0.080 |
Why?
| | Models, Animal | 1 | 2009 | 363 | 0.080 |
Why?
| | Creatine Kinase | 3 | 2015 | 75 | 0.080 |
Why?
| | Eating | 1 | 2010 | 369 | 0.080 |
Why?
| | Adolescent | 5 | 2022 | 18480 | 0.080 |
Why?
| | Point Mutation | 1 | 2008 | 228 | 0.080 |
Why?
| | Multigene Family | 1 | 2008 | 200 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2010 | 1293 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2008 | 481 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 404 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 872 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2008 | 546 | 0.070 |
Why?
| | Young Adult | 4 | 2022 | 10793 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 341 | 0.070 |
Why?
| | Forkhead Box Protein O1 | 1 | 2006 | 15 | 0.070 |
Why?
| | Protein Kinases | 1 | 2008 | 310 | 0.070 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2006 | 5 | 0.070 |
Why?
| | Leptin | 1 | 2008 | 231 | 0.070 |
Why?
| | Cerebrospinal Fluid | 1 | 2007 | 93 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 770 | 0.070 |
Why?
| | Animals, Newborn | 4 | 2001 | 806 | 0.070 |
Why?
| | NF-kappa B | 1 | 2010 | 670 | 0.070 |
Why?
| | MyoD Protein | 1 | 2006 | 28 | 0.070 |
Why?
| | Feeding Behavior | 2 | 2022 | 601 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 465 | 0.070 |
Why?
| | Biomarkers | 3 | 2013 | 3588 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 369 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2006 | 270 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2007 | 307 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1012 | 0.070 |
Why?
| | Dietary Fats | 1 | 2008 | 322 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2008 | 2874 | 0.070 |
Why?
| | Octamer Transcription Factor-1 | 1 | 2005 | 4 | 0.070 |
Why?
| | Cattle | 1 | 2008 | 978 | 0.070 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 279 | 0.070 |
Why?
| | Microspheres | 1 | 2005 | 130 | 0.060 |
Why?
| | Mice, Inbred Strains | 2 | 2002 | 405 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2007 | 233 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 295 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2005 | 154 | 0.060 |
Why?
| | Myocardium | 3 | 2005 | 970 | 0.060 |
Why?
| | Affect | 1 | 2007 | 240 | 0.060 |
Why?
| | Life Style | 1 | 2007 | 430 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2005 | 334 | 0.060 |
Why?
| | Drosophila melanogaster | 2 | 2014 | 200 | 0.060 |
Why?
| | Oligonucleotides | 1 | 2005 | 140 | 0.060 |
Why?
| | Plasmids | 1 | 2005 | 355 | 0.060 |
Why?
| | Cell Count | 3 | 2002 | 315 | 0.060 |
Why?
| | Phenotype | 5 | 2007 | 3003 | 0.060 |
Why?
| | Desmin | 1 | 2003 | 31 | 0.060 |
Why?
| | Blood Proteins | 1 | 2005 | 248 | 0.060 |
Why?
| | Gene Deletion | 1 | 2005 | 361 | 0.060 |
Why?
| | Liver | 1 | 2011 | 1816 | 0.060 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 395 | 0.060 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2002 | 23 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2000 | 702 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2005 | 348 | 0.060 |
Why?
| | Gene Transfer Techniques | 2 | 2003 | 154 | 0.060 |
Why?
| | Enhancer Elements, Genetic | 2 | 2001 | 152 | 0.060 |
Why?
| | Heart Rate | 1 | 2007 | 729 | 0.060 |
Why?
| | Ionophores | 1 | 2002 | 25 | 0.060 |
Why?
| | Calcimycin | 1 | 2002 | 57 | 0.060 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2002 | 56 | 0.060 |
Why?
| | Gene Expression | 4 | 2020 | 1489 | 0.050 |
Why?
| | Motivation | 1 | 2007 | 506 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 91 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2002 | 61 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1171 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 823 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 43 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1510 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2009 | 146 | 0.050 |
Why?
| | Molecular Biology | 1 | 2002 | 58 | 0.050 |
Why?
| | Selection, Genetic | 1 | 1984 | 252 | 0.050 |
Why?
| | Mice, SCID | 1 | 2002 | 333 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1597 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2004 | 554 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1774 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1900 | 0.050 |
Why?
| | NADH Tetrazolium Reductase | 1 | 2001 | 2 | 0.050 |
Why?
| | Brain Injuries | 1 | 2007 | 484 | 0.050 |
Why?
| | Child Abuse | 1 | 2007 | 466 | 0.050 |
Why?
| | Antibodies | 1 | 2004 | 392 | 0.050 |
Why?
| | Phosphorylation | 3 | 2014 | 1633 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 297 | 0.050 |
Why?
| | Gravitation | 1 | 2001 | 21 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 298 | 0.050 |
Why?
| | Cell Movement | 2 | 2002 | 896 | 0.050 |
Why?
| | Blood Glucose | 1 | 2010 | 1939 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2007 | 106 | 0.050 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 292 | 0.050 |
Why?
| | Sarcomeres | 1 | 2001 | 91 | 0.050 |
Why?
| | Chemotactic Factors | 1 | 2000 | 51 | 0.050 |
Why?
| | Homozygote | 1 | 2001 | 190 | 0.050 |
Why?
| | Animal Care Committees | 1 | 2020 | 6 | 0.050 |
Why?
| | Factor IX | 1 | 2000 | 34 | 0.050 |
Why?
| | Diet | 1 | 2008 | 1153 | 0.050 |
Why?
| | Heterozygote | 1 | 2001 | 262 | 0.050 |
Why?
| | Dependovirus | 1 | 2000 | 52 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 2 | 2002 | 51 | 0.040 |
Why?
| | Antigens, CD | 1 | 2002 | 460 | 0.040 |
Why?
| | Propionates | 1 | 1999 | 35 | 0.040 |
Why?
| | Reference Values | 1 | 2001 | 774 | 0.040 |
Why?
| | Transgenes | 1 | 2000 | 174 | 0.040 |
Why?
| | Myosins | 2 | 2000 | 130 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 302 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 827 | 0.040 |
Why?
| | RNA Interference | 1 | 2020 | 460 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2009 | 1085 | 0.040 |
Why?
| | Period Circadian Proteins | 2 | 2014 | 22 | 0.040 |
Why?
| | Cats | 2 | 1995 | 205 | 0.040 |
Why?
| | Wound Healing | 1 | 2000 | 270 | 0.040 |
Why?
| | Oligopeptides | 1 | 2000 | 252 | 0.040 |
Why?
| | Genes, Insect | 1 | 1997 | 22 | 0.040 |
Why?
| | Alcoholism | 1 | 1984 | 717 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2008 | 372 | 0.040 |
Why?
| | Cytoplasm | 1 | 1997 | 269 | 0.040 |
Why?
| | Cell Wall | 2 | 2011 | 53 | 0.040 |
Why?
| | DNA, Bacterial | 2 | 2008 | 314 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1308 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2000 | 446 | 0.040 |
Why?
| | Myalgia | 1 | 2015 | 15 | 0.030 |
Why?
| | Chromatography, Liquid | 2 | 2009 | 355 | 0.030 |
Why?
| | Visual Analog Scale | 1 | 2015 | 31 | 0.030 |
Why?
| | Staphylococcal Infections | 2 | 2011 | 346 | 0.030 |
Why?
| | Decerebrate State | 1 | 1995 | 4 | 0.030 |
Why?
| | Myosin Subfragments | 1 | 1995 | 22 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 758 | 0.030 |
Why?
| | Atrophy | 1 | 1995 | 164 | 0.030 |
Why?
| | Isoantigens | 1 | 1994 | 19 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2014 | 16 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1994 | 184 | 0.030 |
Why?
| | Receptors, Somatotropin | 1 | 1993 | 9 | 0.030 |
Why?
| | United Kingdom | 1 | 1994 | 236 | 0.030 |
Why?
| | Pregnancy | 3 | 1992 | 5691 | 0.030 |
Why?
| | Immunosorbent Techniques | 1 | 1992 | 18 | 0.030 |
Why?
| | Coombs Test | 1 | 1992 | 5 | 0.030 |
Why?
| | Volition | 2 | 2003 | 33 | 0.030 |
Why?
| | Citrate (si)-Synthase | 2 | 2003 | 49 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 1992 | 123 | 0.030 |
Why?
| | Mass Spectrometry | 2 | 2007 | 681 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2000 | 940 | 0.030 |
Why?
| | Molecular Typing | 1 | 2011 | 18 | 0.030 |
Why?
| | Daptomycin | 1 | 2011 | 19 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2007 | 755 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2000 | 942 | 0.030 |
Why?
| | Leg | 1 | 2013 | 234 | 0.030 |
Why?
| | HLA Antigens | 1 | 1992 | 230 | 0.030 |
Why?
| | Rh Isoimmunization | 1 | 1991 | 3 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 1992 | 181 | 0.020 |
Why?
| | Rh-Hr Blood-Group System | 1 | 1991 | 12 | 0.020 |
Why?
| | Muscle Strength | 1 | 2013 | 283 | 0.020 |
Why?
| | Vancomycin | 1 | 2011 | 79 | 0.020 |
Why?
| | Cell Cycle | 1 | 1993 | 550 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4708 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 302 | 0.020 |
Why?
| | Receptors, Fibronectin | 2 | 2000 | 6 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 140 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3730 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2009 | 54 | 0.020 |
Why?
| | Rats, Wistar | 2 | 2001 | 399 | 0.020 |
Why?
| | Oxidation-Reduction | 2 | 2003 | 940 | 0.020 |
Why?
| | Biofilms | 1 | 2011 | 231 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 1994 | 1868 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 160 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2000 | 1974 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 453 | 0.020 |
Why?
| | Kinetics | 3 | 2000 | 1624 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 62 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2007 | 33 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 119 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 421 | 0.020 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 533 | 0.020 |
Why?
| | Fibroblasts | 2 | 2003 | 842 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 171 | 0.020 |
Why?
| | Lipocalins | 1 | 2007 | 38 | 0.020 |
Why?
| | Cystatin C | 1 | 2007 | 69 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2000 | 2220 | 0.020 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2007 | 59 | 0.020 |
Why?
| | Haptoglobins | 1 | 2007 | 49 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 150 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 135 | 0.020 |
Why?
| | Immunoblotting | 1 | 2007 | 307 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 131 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1067 | 0.020 |
Why?
| | Cell Division | 2 | 2000 | 776 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 37 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 65 | 0.020 |
Why?
| | Albumins | 1 | 2005 | 100 | 0.020 |
Why?
| | Nicotine | 1 | 2007 | 276 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 83 | 0.020 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 1984 | 8 | 0.020 |
Why?
| | Purpura | 1 | 2004 | 12 | 0.020 |
Why?
| | Genes, Dominant | 1 | 1984 | 96 | 0.020 |
Why?
| | Isomerism | 1 | 2003 | 43 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 360 | 0.010 |
Why?
| | Exploratory Behavior | 1 | 1984 | 90 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 706 | 0.010 |
Why?
| | Motor Skills | 1 | 1984 | 85 | 0.010 |
Why?
| | Muscle Cells | 1 | 2003 | 42 | 0.010 |
Why?
| | Protein Kinase C-epsilon | 1 | 2002 | 31 | 0.010 |
Why?
| | Peptide Mapping | 1 | 2002 | 63 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2002 | 15 | 0.010 |
Why?
| | RNA Precursors | 1 | 2003 | 136 | 0.010 |
Why?
| | CHO Cells | 1 | 2002 | 143 | 0.010 |
Why?
| | Coloring Agents | 1 | 2002 | 73 | 0.010 |
Why?
| | Cricetinae | 1 | 2002 | 262 | 0.010 |
Why?
| | Electrophoresis | 1 | 2001 | 26 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 618 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 276 | 0.010 |
Why?
| | Seizures | 1 | 1984 | 345 | 0.010 |
Why?
| | Animals, Suckling | 1 | 2000 | 12 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2000 | 67 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 490 | 0.010 |
Why?
| | Autoimmune Diseases | 1 | 2004 | 398 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 32 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1094 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 397 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1487 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 95 | 0.010 |
Why?
| | Putrescine | 1 | 1999 | 4 | 0.010 |
Why?
| | Oxaloacetic Acid | 1 | 1999 | 3 | 0.010 |
Why?
| | Virion | 1 | 2000 | 78 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 1999 | 30 | 0.010 |
Why?
| | Echocardiography | 1 | 2002 | 556 | 0.010 |
Why?
| | Formates | 1 | 1999 | 13 | 0.010 |
Why?
| | Citrates | 1 | 1999 | 48 | 0.010 |
Why?
| | Citric Acid Cycle | 1 | 1999 | 45 | 0.010 |
Why?
| | Methylmalonic Acid | 1 | 1999 | 60 | 0.010 |
Why?
| | Trehalose | 1 | 1999 | 35 | 0.010 |
Why?
| | Citric Acid | 1 | 1999 | 34 | 0.010 |
Why?
| | Chemotaxis | 1 | 2000 | 137 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1999 | 311 | 0.010 |
Why?
| | Succinic Acid | 1 | 1999 | 46 | 0.010 |
Why?
| | Alanine | 1 | 1999 | 102 | 0.010 |
Why?
| | Protons | 1 | 1999 | 79 | 0.010 |
Why?
| | Pyruvic Acid | 1 | 1999 | 48 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 1999 | 115 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 2000 | 114 | 0.010 |
Why?
| | Keratinocytes | 1 | 2000 | 227 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 522 | 0.010 |
Why?
| | Glycine | 1 | 1999 | 162 | 0.010 |
Why?
| | Sex Factors | 1 | 1984 | 1781 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2000 | 462 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2000 | 874 | 0.010 |
Why?
| | DNA, Viral | 1 | 2000 | 356 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2000 | 544 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1999 | 224 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1004 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1999 | 508 | 0.010 |
Why?
| | Feedback | 1 | 1997 | 153 | 0.010 |
Why?
| | Exercise Test | 1 | 1999 | 551 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1047 | 0.010 |
Why?
| | Brain | 1 | 2007 | 2490 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1995 | 44 | 0.010 |
Why?
| | Mass Screening | 1 | 2002 | 1052 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 62 | 0.010 |
Why?
| | Age Factors | 1 | 2001 | 2995 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9342 | 0.010 |
Why?
| | Infant | 1 | 2007 | 8293 | 0.010 |
Why?
| | Insulin | 2 | 1993 | 2162 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 9491 | 0.010 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 1992 | 4 | 0.010 |
Why?
| | Adipocytes | 1 | 1993 | 199 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 683 | 0.010 |
Why?
| | England | 1 | 1991 | 68 | 0.010 |
Why?
| | Collagen | 1 | 1992 | 433 | 0.010 |
Why?
| | Fetal Blood | 1 | 1991 | 272 | 0.010 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 349 | 0.010 |
Why?
| | Middle Aged | 1 | 2007 | 27617 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2424 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 12978 | 0.000 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|